
欧洲制药填充和表面处理外包市场预测至 2028 年 - COVID-19 影响和按成品状态(固体、半固体和液体)、内容(从动物源分离的有机物质、从微生物分离的有机物质和无机物)
No. of Pages: 135 | Report Code: TIPRE00027252 | Category: Life Sciences
No. of Pages: 135 | Report Code: TIPRE00027252 | Category: Life Sciences
传统上,灌装和包装操作是最常见的外包生物制药生产活动。由于制造技术成本高昂,生物制剂的最终配方需要广泛关注,其中产品安全因素是合同制造商的首要任务。新技术的使用加上合同制造组织的工厂产能扩张预计将在预测期内推动药品灌装和成品外包市场。 2021 年 7 月,合同开发商和制造组织 Curia 宣布达成协议,收购从事提供填充/饰面配方产品的 Integrity Bio 公司。据正式报道,被收购的公司生产 60 多种大分子,最近增加了灌装/成品生产线,使其生产设施增加了一倍。此次收购以有利的方式补充了 Curia,推动了近期药品灌装和成品外包市场的增长,并且预计在预测期内将继续保持相同的趋势。
p>
COVID-19 大流行的爆发严重影响了欧洲制药公司在生产和销售方面的组织绩效。例如,德国监管机构实施降价措施,导致固体制剂领域增长放缓。然而,在欧洲疫情爆发期间,对合同制造的需求加速。在欧盟中,无论是产能还是市场份额,德国都可能继续成为西欧最大的合同制造市场。此外,疫情期间,欧洲由于该地区临床试验数量多、原料药生产基地庞大、制造能力先进、领先药企云集以及仿制药市场增长,在药品灌装外包方面占据了相当大的市场。欧洲制造商越来越多地使用 CDMO 来生产 COVID-19 疫苗,这影响了扩张计划,并降低了获得现有生产位置的灵活性。自 COVID-19 爆发以来,全球疫苗合同制造市场经历了显着增长。
借助新功能和技术,供应商可以吸引新客户并扩大其在新兴市场的足迹。这一因素可能会推动药品灌装和成品外包市场。欧洲药品灌装和成品外包市场预计在预测期内将以良好的复合年增长率增长。
提及的公司
Strategic insights for Europe Pharmaceutical Fill and Finish Outsourcing involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
Report Attribute | Details |
---|---|
Market size in 2021 | US$ 865.4 Million |
Market Size by 2028 | US$ 1,295.0 Million |
Global CAGR (2021 - 2028) | 5.9% |
Historical Data | 2019-2020 |
Forecast period | 2022-2028 |
Segments Covered |
By 成品状态
|
Regions and Countries Covered | 欧洲
|
Market leaders and key company profiles |
The regional scope of Europe Pharmaceutical Fill and Finish Outsourcing refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The Europe Pharmaceutical Fill and Finish Outsourcing Market is valued at US$ 865.4 Million in 2021, it is projected to reach US$ 1,295.0 Million by 2028.
As per our report Europe Pharmaceutical Fill and Finish Outsourcing Market, the market size is valued at US$ 865.4 Million in 2021, projecting it to reach US$ 1,295.0 Million by 2028. This translates to a CAGR of approximately 5.9% during the forecast period.
The Europe Pharmaceutical Fill and Finish Outsourcing Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Pharmaceutical Fill and Finish Outsourcing Market report:
The Europe Pharmaceutical Fill and Finish Outsourcing Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Europe Pharmaceutical Fill and Finish Outsourcing Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Europe Pharmaceutical Fill and Finish Outsourcing Market value chain can benefit from the information contained in a comprehensive market report.